兩連板的藍英裝備(300293.SZ):主營業務為工業清洗系統及表面處理系統業務和智能裝備製造業務
格隆匯3月18日丨連續2個漲停的藍英裝備(300293.SZ)發佈公告稱,公司主營業務為工業清洗系統及表面處理系統業務和智能裝備製造業務,公司主營業務未發生變化。公司的設備主要應用於電子、光學、半導體、汽車、通信、機械、醫療、航空航天等領域。
公司於2020年2月28日披露了《2019年度業績快報》,經公司財務部門初步測算的結果,公司2019年度實現營業總收入14.73億元。以上數據未經審計,與2019年度報告中披露的最終數據可能存在差異,請投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.